Established in 2002, Yasoo Health is a Health Science Company based in Johnson City Tennessee with an international branch in Nicosia Cyprus. Our focus is the development of a range of condition-specific products, initially targeted at the management of disease by relieving oxidative stress due to malabsorption of lipophilic compounds. This is a common problem associated with diseases such as Cystic Fibrosis, Inflammatory Bowel Disease (IBD), Crohn's Disease, Cholestasis, HIV and others.

Aqua-E, the first malabsorption product developed, is a liquid, water-soluble formulation of Vitamin E containing the complete family of tocopherols and tocotrienols. It has been formulated and clinically tested for supplementation in conditions of malabsorption that could lead to Vitamin E deficiency.

Following successful clinical trials, we developed AquADEKs, a proprietary nutraceutical product as adjuvant therapy for Cystic Fibrosis patients. AquADEKs is marketed and distributed by Axcan Pharma Inc. The commercialization of AquADEKs was supported by the Cystic Fibrosis Foundation and is generally recognized as advancing the standard of nutritional care for Cystic Fibrosis patients.

Building on our expertise in testing and validating a range of new nutritional formulations, natural products and in-licensed proprietary drugs, we are bringing to market a number of condition-specific products based on our proprietary technology and supported by clinical trials. Our initial focus is in areas such as IBD, Cholestasis and HIV/ AIDS.

Yasoo Health is developing innovative, science based proprietary products, based on nutrients and natural compounds, to meet the important needs in the Prevention and Management of chronic disease and the promotion of wellness and quality of life.

To achieve this Mission, we are integrating three major fields of knowledge: